Cognition Therapeutics, Inc. (CGTX) came out with a quarterly loss of $0.04 per share versus the Zac

PURCHASE, N.Y., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), a cli

PURCHASE, N. Y. , July 13, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a c

Cognition Therapeutics is currently prioritizing zervimesine for DLB psychosis. This is after the FD

Gainers Pulsenmore (NASDAQ:PLSM) shares moved upwards by 160.5% to $8.88 during Wednesday's reg

- Zervimesine Would be the First Long-term, Durable Treatment Option with an Impact on Underlying Di

PURCHASE, N.Y., June 16, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “C

PURCHASE, N.Y., June 01, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a cli

- Positive Discussion on Path Forward for Registrational Program - PURCHASE, N.Y., May 21, 2026 (GLO

PURCHASE, N.Y., May 14, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Co

Meeting with FDA Division of Psychiatry scheduled for May 2026 expected to inform registrational pla

Cognition Therapeutics, Inc. (NASDAQ: CGTX - Get Free Report) CEO Lisa Ricciardi bought 9,175 shares

Cognition Therapeutics, Inc. (NASDAQ: CGTX - Get Free Report) CFO John Brendan Doyle acquired 10,000

Cognition Therapeutics (NASDAQ: CGTX) executives told investors at the Needham conference that the c

PURCHASE, N.Y., April 07, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a cl

Advancing Zervimesine (CT1812) towards late-stage trials for  dementia with Lewy bodies (DLB) psycho

Cognition Therapeutics (NASDAQ: CGTX) used its fourth-quarter and full-year 2025 earnings call to ou

Cognition Therapeutics, Inc. (CGTX) Q4 2025 Earnings Call Transcript

-Advancing zervimesine clinical development in DLB psychosis –  - Meeting with FDA Division of Psych

PURCHASE, N.Y., March 23, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a cl

Shares of Sapiens International Corporation NV (NASDAQ:SPNS) rose sharply in pre-market trading afte

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s sessi

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea

Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique

  Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to repor

Gainers

Gainers Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday.

  On Wednesday, 329 companies hit new 52-week lows.

Gainers  

Gainers Splash Beverage Group, Inc. (NYSE: SBEV) shares jumped 70.6% to close at $1.80 on Tuesday

Gainers TSR, Inc. (NASDAQ: TSRI) shares climbed 36.6% to $12.21 following Q2 results. The compan